StockData
Korsana Biosciences, Inc. logo

Korsana Biosciences, Inc. (KRSA) stock

KRSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30508% above fair value
$33.27+0.77 (+2.37%)

Close on Nov 18, 2026Market cap $155.75MP/E –Yield –

Korsana Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Korsana Biosciences's price to sales ratio was 71.3× on Nov 11, 2026, against 14.3× a year earlier. Over the last 5 years it ranged from 5.7× to 445.0×, with a median of 113.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202671.3×+59.8
2025Dec 31, 202511.5×−282.5
2024Dec 31, 2024294.1×+134.9
2023Jul 31, 2023159.1×+30.2
2022Dec 30, 2022128.9×−18.3
2021Dec 31, 2021147.2×−52.4
2020Dec 31, 2020199.6×–

More Korsana Biosciences figures

See a number that looks wrong?